Global Induced Pluripotent Stem Cells (iPSCs) Market Insights and Forecast to 2028

Report ID: 1549823 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Human iPSCs
        1.2.3 Mouse iPSCs
    1.3 Market by Application
        1.3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Academic Research
        1.3.3 Drug Development and Discovery
        1.3.4 Toxicity Screening
        1.3.5 Regenerative Medicine
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Perspective (2017-2028)
    2.2 Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Region
        2.2.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Region (2017-2022)
        2.2.3 Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Region (2023-2028)
    2.3 Induced Pluripotent Stem Cells (iPSCs) Market Dynamics
        2.3.1 Induced Pluripotent Stem Cells (iPSCs) Industry Trends
        2.3.2 Induced Pluripotent Stem Cells (iPSCs) Market Drivers
        2.3.3 Induced Pluripotent Stem Cells (iPSCs) Market Challenges
        2.3.4 Induced Pluripotent Stem Cells (iPSCs) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Revenue
        3.1.1 Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Revenue (2017-2022)
        3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2017-2022)
    3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Induced Pluripotent Stem Cells (iPSCs) Revenue
    3.4 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio
        3.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2021
    3.5 Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Area Served
    3.6 Key Players Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service
    3.7 Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Type
    4.1 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Type (2017-2022)
    4.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2023-2028)
5 Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Application
    5.1 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Application (2017-2022)
    5.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size (2017-2028)
    6.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
        6.2.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022)
        6.2.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2023-2028)
        6.2.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2017-2028)
    6.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
        6.3.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022)
        6.3.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2023-2028)
        6.3.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2017-2028)
    6.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
        6.4.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2017-2022)
        6.4.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (2017-2028)
    7.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
        7.2.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022)
        7.2.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2023-2028)
        7.2.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2017-2028)
    7.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
        7.3.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022)
        7.3.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2023-2028)
        7.3.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2017-2028)
    7.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
        7.4.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2017-2022)
        7.4.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size (2017-2028)
    8.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
        8.2.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2017-2028)
    8.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
        8.3.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2017-2028)
    8.4 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region
        8.4.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size (2017-2028)
    9.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
        9.2.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022)
        9.2.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2023-2028)
        9.2.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2017-2028)
    9.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
        9.3.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022)
        9.3.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2023-2028)
        9.3.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2017-2028)
    9.4 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
        9.4.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2017-2022)
        9.4.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size (2017-2028)
    10.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
        10.2.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2017-2028)
    10.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
        10.3.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2017-2028)
    10.4 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
        10.4.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Fujifilm Holding Corporation (CDI)
        11.1.1 Fujifilm Holding Corporation (CDI) Company Details
        11.1.2 Fujifilm Holding Corporation (CDI) Business Overview
        11.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Introduction
        11.1.4 Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
        11.1.5 Fujifilm Holding Corporation (CDI) Recent Developments
    11.2 Ncardia
        11.2.1 Ncardia Company Details
        11.2.2 Ncardia Business Overview
        11.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Introduction
        11.2.4 Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
        11.2.5 Ncardia Recent Developments
    11.3 Sumitomo Dainippon Pharma
        11.3.1 Sumitomo Dainippon Pharma Company Details
        11.3.2 Sumitomo Dainippon Pharma Business Overview
        11.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Introduction
        11.3.4 Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
        11.3.5 Sumitomo Dainippon Pharma Recent Developments
    11.4 Astellas Pharma Inc
        11.4.1 Astellas Pharma Inc Company Details
        11.4.2 Astellas Pharma Inc Business Overview
        11.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Introduction
        11.4.4 Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
        11.4.5 Astellas Pharma Inc Recent Developments
    11.5 Fate Therapeutics, Inc
        11.5.1 Fate Therapeutics, Inc Company Details
        11.5.2 Fate Therapeutics, Inc Business Overview
        11.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Introduction
        11.5.4 Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
        11.5.5 Fate Therapeutics, Inc Recent Developments
    11.6 Pluricell Biotech
        11.6.1 Pluricell Biotech Company Details
        11.6.2 Pluricell Biotech Business Overview
        11.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Introduction
        11.6.4 Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
        11.6.5 Pluricell Biotech Recent Developments
    11.7 Cell Inspire Biotechnology
        11.7.1 Cell Inspire Biotechnology Company Details
        11.7.2 Cell Inspire Biotechnology Business Overview
        11.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Introduction
        11.7.4 Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
        11.7.5 Cell Inspire Biotechnology Recent Developments
    11.8 ReproCELL
        11.8.1 ReproCELL Company Details
        11.8.2 ReproCELL Business Overview
        11.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Introduction
        11.8.4 ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
        11.8.5 ReproCELL Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Human iPSCs
    Table 3. Key Players of Mouse iPSCs
    Table 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2017-2022)
    Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2023-2028)
    Table 10. Induced Pluripotent Stem Cells (iPSCs) Market Trends
    Table 11. Induced Pluripotent Stem Cells (iPSCs) Market Drivers
    Table 12. Induced Pluripotent Stem Cells (iPSCs) Market Challenges
    Table 13. Induced Pluripotent Stem Cells (iPSCs) Market Restraints
    Table 14. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Players (2017-2022)
    Table 16. Global Top Induced Pluripotent Stem Cells (iPSCs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2021)
    Table 17. Ranking of Global Top Induced Pluripotent Stem Cells (iPSCs) Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service
    Table 21. Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2017-2022)
    Table 25. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2023-2028)
    Table 27. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application (2017-2022)
    Table 29. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application (2023-2028)
    Table 31. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Fujifilm Holding Corporation (CDI) Company Details
    Table 62. Fujifilm Holding Corporation (CDI) Business Overview
    Table 63. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product
    Table 64. Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022) & (US$ Million)
    Table 65. Fujifilm Holding Corporation (CDI) Recent Developments
    Table 66. Ncardia Company Details
    Table 67. Ncardia Business Overview
    Table 68. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product
    Table 69. Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022) & (US$ Million)
    Table 70. Ncardia Recent Developments
    Table 71. Sumitomo Dainippon Pharma Company Details
    Table 72. Sumitomo Dainippon Pharma Business Overview
    Table 73. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product
    Table 74. Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022) & (US$ Million)
    Table 75. Sumitomo Dainippon Pharma Recent Developments
    Table 76. Astellas Pharma Inc Company Details
    Table 77. Astellas Pharma Inc Business Overview
    Table 78. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product
    Table 79. Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022) & (US$ Million)
    Table 80. Astellas Pharma Inc Recent Developments
    Table 81. Fate Therapeutics, Inc Company Details
    Table 82. Fate Therapeutics, Inc Business Overview
    Table 83. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product
    Table 84. Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022) & (US$ Million)
    Table 85. Fate Therapeutics, Inc Recent Developments
    Table 86. Pluricell Biotech Company Details
    Table 87. Pluricell Biotech Business Overview
    Table 88. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product
    Table 89. Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022) & (US$ Million)
    Table 90. Pluricell Biotech Recent Developments
    Table 91. Cell Inspire Biotechnology Company Details
    Table 92. Cell Inspire Biotechnology Business Overview
    Table 93. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product
    Table 94. Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022) & (US$ Million)
    Table 95. Cell Inspire Biotechnology Recent Developments
    Table 96. ReproCELL Company Details
    Table 97. ReproCELL Business Overview
    Table 98. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product
    Table 99. ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022) & (US$ Million)
    Table 100. ReproCELL Recent Developments
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Type: 2021 VS 2028
    Figure 2. Human iPSCs Features
    Figure 3. Mouse iPSCs Features
    Figure 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2021 VS 2028
    Figure 5. Academic Research Case Studies
    Figure 6. Drug Development and Discovery Case Studies
    Figure 7. Toxicity Screening Case Studies
    Figure 8. Regenerative Medicine Case Studies
    Figure 9. Others Case Studies
    Figure 10. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered
    Figure 11. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Induced Pluripotent Stem Cells (iPSCs) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Region: 2021 VS 2028
    Figure 14. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Players in 2021
    Figure 15. Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2021
    Figure 17. North America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2017-2028)
    Figure 19. North America Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2017-2028)
    Figure 20. North America Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Country (2017-2028)
    Figure 21. United States Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Country (2017-2028)
    Figure 27. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Region (2017-2028)
    Figure 37. China Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Country (2017-2028)
    Figure 47. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Country (2017-2028)
    Figure 53. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Fujifilm Holding Corporation (CDI) Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
    Figure 57. Ncardia Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
    Figure 58. Sumitomo Dainippon Pharma Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
    Figure 59. Astellas Pharma Inc Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
    Figure 60. Fate Therapeutics, Inc Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
    Figure 61. Pluricell Biotech Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
    Figure 62. Cell Inspire Biotechnology Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
    Figure 63. ReproCELL Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
Frequently Asked Questions
Induced Pluripotent Stem Cells (iPSCs) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Induced Pluripotent Stem Cells (iPSCs) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Induced Pluripotent Stem Cells (iPSCs) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

26650 Battery Pack

26650 Battery Pack market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More

Industrial Fans

Industrial Fans market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Ergothioneine (EGT)

Ergothioneine (EGT) market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More